ALEXANDRIA, Va., July 7 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'OSSYNTO' in its latest official gazette. The trademark application with the serial number 98683380 was filed on Aug. 5, 2024.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for use in the treatment of bone metastases from breast, prostate, and other solid tumors or cancer and multiple myeloma
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Amneal Pharmaceuticals LLC 400 Crossing Boulevard, Third Floor Bridgewater NJ New Jersey 08807 16 LIMITED LIABILITY COMPANY
Disclaimer: Curated by HT Syndication....